192 related articles for article (PubMed ID: 9253334)
1. Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors.
Gicquel C; Raffin-Sanson ML; Gaston V; Bertagna X; Plouin PF; Schlumberger M; Louvel A; Luton JP; Le Bouc Y
J Clin Endocrinol Metab; 1997 Aug; 82(8):2559-65. PubMed ID: 9253334
[TBL] [Abstract][Full Text] [Related]
2. Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors.
Gicquel C; Bertagna X; Schneid H; Francillard-Leblond M; Luton JP; Girard F; Le Bouc Y
J Clin Endocrinol Metab; 1994 Jun; 78(6):1444-53. PubMed ID: 7911125
[TBL] [Abstract][Full Text] [Related]
3. High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors.
Bourcigaux N; Gaston V; Logié A; Bertagna X; Le Bouc Y; Gicquel C
J Clin Endocrinol Metab; 2000 Jan; 85(1):322-30. PubMed ID: 10634406
[TBL] [Abstract][Full Text] [Related]
4. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.
Gicquel C; Bertagna X; Gaston V; Coste J; Louvel A; Baudin E; Bertherat J; Chapuis Y; Duclos JM; Schlumberger M; Plouin PF; Luton JP; Le Bouc Y
Cancer Res; 2001 Sep; 61(18):6762-7. PubMed ID: 11559548
[TBL] [Abstract][Full Text] [Related]
5. Molecular markers for malignancy in adrenocortical tumors.
Gicquel C; Le Bouc Y
Horm Res; 1997; 47(4-6):269-72. PubMed ID: 9167963
[TBL] [Abstract][Full Text] [Related]
6. Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression.
Wilkin F; Gagné N; Paquette J; Oligny LL; Deal C
J Clin Endocrinol Metab; 2000 May; 85(5):2048-56. PubMed ID: 10843195
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors.
Boulle N; Logié A; Gicquel C; Perin L; Le Bouc Y
J Clin Endocrinol Metab; 1998 May; 83(5):1713-20. PubMed ID: 9589681
[TBL] [Abstract][Full Text] [Related]
8. Ribonucleic acid expression of the clustered imprinted genes, p57KIP2, insulin-like growth factor II, and H19, in adrenal tumors and cultured adrenal cells.
Liu J; Kahri AI; Heikkilä P; Voutilainen R
J Clin Endocrinol Metab; 1997 Jun; 82(6):1766-71. PubMed ID: 9177379
[TBL] [Abstract][Full Text] [Related]
9. Genomic imprinting and Wilms' tumor.
Moulton T; Chung WY; Yuan L; Hensle T; Waber P; Nisen P; Tycko B
Med Pediatr Oncol; 1996 Nov; 27(5):476-83. PubMed ID: 8827077
[TBL] [Abstract][Full Text] [Related]
10. [Sporadic adrenocortical tumors: genetics and perspectives for the pathologist].
Tissier F
Ann Pathol; 2008 Oct; 28(5):409-16. PubMed ID: 19068395
[TBL] [Abstract][Full Text] [Related]
11. [Involvement of the IGF system in the pathogenesis of adrenocortical tumors].
Gicquel C; Boulle N; Logié A; Bourcigaux N; Gaston V; Le Bouc Y
Ann Endocrinol (Paris); 2001 Apr; 62(2):189-92. PubMed ID: 11353893
[TBL] [Abstract][Full Text] [Related]
12. A case report in favor of a multistep adrenocortical tumorigenesis.
Bernard MH; Sidhu S; Berger N; Peix JL; Marsh DJ; Robinson BG; Gaston V; Le Bouc Y; Gicquel C
J Clin Endocrinol Metab; 2003 Mar; 88(3):998-1001. PubMed ID: 12629075
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor system on adrenocortical tumorigenesis.
Ribeiro TC; Latronico AC
Mol Cell Endocrinol; 2012 Mar; 351(1):96-100. PubMed ID: 22019903
[TBL] [Abstract][Full Text] [Related]
14. Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis.
Fottner Ch; Hoeflich A; Wolf E; Weber MM
Horm Metab Res; 2004 Jun; 36(6):397-405. PubMed ID: 15241731
[TBL] [Abstract][Full Text] [Related]
15. High frequency of loss of heterozygosity at 11p15 and IGF2 overexpression are not related to clinical outcome in childhood adrenocortical tumors positive for the R337H TP53 mutation.
Rosati R; Cerrato F; Doghman M; Pianovski MA; Parise GA; Custódio G; Zambetti GP; Ribeiro RC; Riccio A; Figueiredo BC; Lalli E
Cancer Genet Cytogenet; 2008 Oct; 186(1):19-24. PubMed ID: 18786438
[TBL] [Abstract][Full Text] [Related]
16. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor.
Yballe CM; Vu TH; Hoffman AR
J Clin Endocrinol Metab; 1996 Apr; 81(4):1607-12. PubMed ID: 8636375
[TBL] [Abstract][Full Text] [Related]
17. Association of H19 promoter methylation with the expression of H19 and IGF-II genes in adrenocortical tumors.
Gao ZH; Suppola S; Liu J; Heikkilä P; Jänne J; Voutilainen R
J Clin Endocrinol Metab; 2002 Mar; 87(3):1170-6. PubMed ID: 11889182
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity at the mannose 6-phosphate/insulin-like growth factor 2 receptor locus: a frequent but late event in adrenocortical tumorigenesis.
Leboulleux S; Gaston V; Boulle N; Le Bouc Y; Gicquel C
Eur J Endocrinol; 2001 Feb; 144(2):163-8. PubMed ID: 11182753
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome.
Gaston V; Le Bouc Y; Soupre V; Burglen L; Donadieu J; Oro H; Audry G; Vazquez MP; Gicquel C
Eur J Hum Genet; 2001 Jun; 9(6):409-18. PubMed ID: 11436121
[TBL] [Abstract][Full Text] [Related]
20. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas.
Wu HK; Squire JA; Catzavelos CG; Weksberg R
Biochem Biophys Res Commun; 1997 Jun; 235(1):123-9. PubMed ID: 9196048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
